Chad Tang

Assistant Professor

  • 3800 Citations
  • 29 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Chad Tang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Radiotherapy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Radiation Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Pluripotent Stem Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

1 Citation (Scopus)

Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial

Pasalic, D., Kuban, D. A., Allen, P. K., Tang, C., Mesko, S. M., Grant, S. R., Augustyn, A. A., Frank, S. J., Choi, S., Hoffman, K., Nguyen, Q-N., McGuire, S. E., Pollack, A. & Anscher, M. S., Jul 15 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 4, p. 790-797 8 p.

Research output: Contribution to journalArticle

Prostate
Adenocarcinoma
Randomized Controlled Trials
Confidence Intervals
dosage

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

Menon, H., Chen, D., Ramapriyan, R., Verma, V., Barsoumian, H. B., Cushman, T. R., Younes, A. I., Cortez, M. A., Erasmus, J. J., De Groot, P., Carter, B. W., Hong, D. S., Glitza, I. C., Ferrarotto, R., Altan, M., Diab, A., Chun, S. G., Heymach, J. V., Tang, C., Nguyen, Q. N. & 1 others, Welsh, J. W., Sep 4 2019, In : Journal for immunotherapy of cancer. 7, 1, 237.

Research output: Contribution to journalArticle

Open Access
Immunotherapy
Radiation
Neoplasms
34 Citations (Scopus)

Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study

Gomez, D., Tang, C., Zhang, J., Blumenschein, G. R., Hernandez, M., Lee, J-K. J., Ye, R., Palma, D. A., Louie, A. V., Ross Camidge, D., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Welsh, J., Gibbons, D. L., Karam, J. A., Kavanagh, B. D., Tsao, A., Sepesi, B., Swisher, S. G. & 1 others, Heymach, J. V., Jan 1 2019, In : Journal of Clinical Oncology. 37, 18, p. 1558-1565 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Observation
Disease-Free Survival
Therapeutics
Survival
1 Citation (Scopus)

Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment

Reichard, C. A., Hoffman, K. E., Tang, C., Williams, S. B., Allen, P. K., Achim, M. F., Kuban, D. A. & Chapin, B. F., Nov 1 2019, In : BJU International. 124, 5, p. 811-819 9 p.

Research output: Contribution to journalArticle

Prostatectomy
Prostatic Neoplasms
Radiotherapy
Epidemiology
Confidence Intervals
33 Citations (Scopus)

State-of-the-art strategies for targeting the DNA damage response in cancer

Pilie, P. G., Tang, C., Mills, G. B. & Yap, T. A., Feb 1 2019, In : Nature Reviews Clinical Oncology. 16, 2, p. 81-104 24 p.

Research output: Contribution to journalReview article

DNA Damage
Neoplasms
Therapeutics
Biomarkers
Clonal Evolution